William Kelley - GenVec Independent Director
Director
Dr. William N. Kelley, M.D., is Independent Director of Genvec, Inc. Dr. Kelley is Chairman of the Nominating and Corporationrationrate Governance Committee and a member of the Compensation Committee since 2002.
| Age | 74 |
| Tenure | 22 years |
| Professional Marks | Ph.D |
| Phone | 240-632-0740 |
| Web | http://www.genvec.com |
GenVec Management Efficiency
The company has return on total asset (ROA) of (86.26) % which means that it has lost $86.26 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (248.11) %, meaning that it created substantial loss on money invested by shareholders. GenVec's management efficiency ratios could be used to measure how well GenVec manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Jonathan Chadwick | ServiceNow | 54 | |
| Peter Gilbert | Bel Fuse A | 70 | |
| Frederic Luddy | ServiceNow | 69 | |
| Timothy Furey | Skyworks Solutions | 59 | |
| Raymond Link | FormFactor | 64 | |
| John Johnson | Bel Fuse A | 84 | |
| Susan Bostrom | ServiceNow | 60 | |
| David McLachlan | Skyworks Solutions | 78 | |
| Lothar Maier | FormFactor | 63 | |
| Kelley StevenWaiss | FormFactor | 49 | |
| Jeffrey Miller | ServiceNow | 68 | |
| William Strauss | ServiceNow | 56 | |
| James Champy | Analog Devices | 75 | |
| Avi Eden | Bel Fuse A | 70 | |
| Anita Sands | ServiceNow | 43 | |
| Bruce Evans | Analog Devices | 58 | |
| John Hodgson | Analog Devices | 71 | |
| Richard DeLateur | FormFactor | 59 | |
| Kenton Sicchitano | Analog Devices | 73 | |
| Karen Golz | Analog Devices | 63 | |
| Lisa Su | Analog Devices | 48 | |
Management Performance
| Return On Equity | -248.11 | |||
| Return On Asset | -86.26 |
GenVec Inc Leadership Team
Elected by the shareholders, the GenVec's board of directors comprises two types of representatives: GenVec inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GenVec. The board's role is to monitor GenVec's management team and ensure that shareholders' interests are well served. GenVec's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GenVec's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Swirsky, President CEO, Director | ||
| Stefan Loren, Director | ||
| Wayne Hockmeyer, Chairman of the Board | ||
| Quinterol Mallette, Director | ||
| Douglas Brough, Chief Scientific Officer | ||
| William Kelley, Independent Director | ||
| Marc Schneebaum, Independent Director | ||
| Michael Richman, Director | ||
| Rena Cohen, IR Contact Officer | ||
| Bryan Butman, Sr. VP of Devel. | ||
| James Lambert, Sr. Director of Accounting and Fin., Treasurer and Corporate Controller |
GenVec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GenVec a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -248.11 | |||
| Return On Asset | -86.26 | |||
| Current Valuation | 25.09 M | |||
| Shares Outstanding | 2.27 M | |||
| Shares Owned By Insiders | 3.97 % | |||
| Shares Owned By Institutions | 32.70 % | |||
| Number Of Shares Shorted | 250.07 K | |||
| Price To Earning | (1.94) X | |||
| Price To Book | 26.25 X | |||
| Price To Sales | 48.80 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards GenVec in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, GenVec's short interest history, or implied volatility extrapolated from GenVec options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in GenVec Stock
If you are still planning to invest in GenVec Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GenVec's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |